๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
Corline Biomedical AB (publ) (STO:CLBIO)
Sweden flag Sweden ยท Delayed Price ยท Currency is SEK
14.00
-0.35 (-2.44%)
Nov 20, 2026, 5:25 PM CET

Corline Biomedical AB Financials Overview

Millions SEK. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
13.447.659.7835.5223.557.06
Revenue Growth
77.79%-21.73%-72.48%50.82%233.48%91.07%
Gross Profit
11.445.295.9428.3813.69-1.03
Operating Income
-13.13-14.79-13.59-2.22.33-6.91
Net Income
-13.74-14.71-23.19-1.812.33-6.92
Earnings Per Share
-0.53-0.59-1.06-0.080.11-0.34
EPS Growth
------

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
29.8720.5617.6717.0126.2141.64
Total Debt
4.363.832.01---
Net Cash (Debt)
25.5116.7215.6617.0126.2141.64
Net Cash Growth
338.40%6.80%-7.96%-35.09%-37.05%363.07%
Net Cash Per Share
0.990.680.720.791.192.04

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-15.37-17.69-8.640.89-6.45-4.84
Capital Expenditures
-0.38-0.05--0.13-0.15-0.14
Free Cash Flow
-15.74-17.74-8.640.75-6.61-4.98
Free Cash Flow Growth
------

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
85.14%69.15%60.81%79.90%58.11%-14.59%
Operating Margin
-97.72%-193.24%-139.01%-6.20%9.89%-97.83%
Pretax Margin
-102.22%-192.31%-237.28%-5.09%9.89%-98.02%
Profit Margin
-102.23%-192.31%-237.28%-5.09%9.89%-98.02%
FCF Margin
-117.13%-231.81%-88.38%2.12%-28.05%-70.45%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
----85.08-
Forward PE
-38.9213.413.90108.00108.00
P/FCF Ratio
---424.69--
PS Ratio
27.2246.0719.309.028.4144.43